Identification of differential pattern of protein expression in canine osteoarthritis serum after anterior cruciate ligament transection: a proteomic analysis.
[en] Osteoarthritis (OA) management remains a great challenge and there is considerable effort to understand its pathophysiology and to identify new therapeutic targets and biomarkers. Canine OA surgically induced by the transection of the anterior cruciate ligament (ACLT) is a widely used and relevant model. This study reports a proteome mapping of dog serum and an analysis of the differentially expressed proteins between before and after ACLT. In the first part of the study, 261 picked protein spots were identified from preparative 2D gels and 71 different proteins were identified among the 261 spots present on the reference map. Canine serum proteome mapping reveals the presence of proteins of interest, such as fetuin B, complement C3 and C1s and pregnancy zone protein. The comparison between serum from dogs before and after ACLT reveals the differential expression of several proteins that could play a key role in the pathogenesis of OA. A number of proteins, such as fetuin B and complement C3, were increased in dog OA serum whereas others, such as hyaluronan binding protein 2, inter-alpha-trypsin inhibitor H4 (ITIH4), complement C1s and C4 and haptoglobin were decreased. Some of these proteins could be candidate biomarkers for diagnosis, prognosis and treatment evaluation. The results of the study also reinforced the similarities between dog experimental OA and human cases of OA.
Disciplines :
Rheumatology
Author, co-author :
Gharbi, Myriam
Sanchez, Christelle ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Mazzucchelli, Gabriel ; Université de Liège - ULiège > Center for Analytical Research and Technology (CART)
De Pauw, Edwin ; Université de Liège - ULiège > Département de chimie (sciences) > GIGA-R : Laboratoire de spectrométrie de masse (L.S.M.)
Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Language :
English
Title :
Identification of differential pattern of protein expression in canine osteoarthritis serum after anterior cruciate ligament transection: a proteomic analysis.
Publication date :
2013
Journal title :
Veterinary Journal
ISSN :
1090-0233
eISSN :
1532-2971
Publisher :
Elsevier, London, United Kingdom
Volume :
197
Issue :
3
Pages :
848-53
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2013 Elsevier Ltd. All rights reserved.
Aspden R.M., Scheven B.A., Hutchison J.D. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357:1118-1120.
Bhattacharyya S., Siegel E.R., Achenbach S.J., Khosla S., Suva L.J. Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. Journal of Bone and Mineral Research 2008, 23:1106-1117.
Boileau C., Martel-Pelletier J., Caron J., Msika P., Guillou G.B., Baudouin C., Pelletier J.P. Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: Inhibition of nitric oxide synthase and matrix metalloproteinase-13. Arthritis Research and Therapy 2009, 11:R41.
Boileau C., Martel-Pelletier J., Caron J., Pare F., Troncy E., Moreau M., Pelletier J.P. Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: Inhibition of protease-activated receptor 2. Annals of the Rheumatic Diseases 2010, 69:1179-1184.
Cayatte A.J., Kumbla L., Subbiah M.T. Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. Journal of Biological Chemistry 1990, 265:5883-5888.
Choi-Miura N.H., Saito K., Takahashi K., Yoda M., Tomita M. Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Biological and Pharmaceutical Bulletin 2001, 24:221-225.
Cook J.L., Kuroki K., Visco D., Pelletier J.P., Schulz L., Lafeber F.P. The OARSI histopathology initiative - Recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis and Cartilage 2010, 18:S66-S79.
De Ceuninck F., Berenbaum F. Proteomics: Addressing the challenges of osteoarthritis. Drug Discovery Today 2009, 14:661-667.
Denecke B., Graber S., Schafer C., Heiss A., Woltje M., Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochemistry Journal 2003, 376:135-145.
Dibonaventura M., Gupta S., McDonald M., Sadosky A. Evaluating the health and economic impact of osteoarthritis pain in the workforce: Results from the National Health and Wellness Survey. BMC Musculoskeletal Disorders 2011, 12:83.
Fernandez-Puente P., Mateos J., Fernandez-Costa C., Oreiro N., Fernandez-Lopez C., Ruiz-Romero C., Blanco F.J. Identification of a panel of novel serum osteoarthritis biomarkers. Journal of Proteome Research 2011, 10:5095-5101.
Frommer K.W., Zimmermann B., Meier F.M., Schroder D., Heil M., Schaffler A., Buchler C., Steinmeyer J., Brentano F., Gay S., et al. Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis and Rheumatism 2010, 62:2886-2899.
Gabay O., Hall D.J., Berenbaum F., Henrotin Y., Sanchez C. Osteoarthritis and obesity: Experimental models. Joint Bone Spine 2008, 75:675-679.
Gharbi M., Deberg M., Henrotin Y. Application for proteomic techniques in studying osteoarthritis: A review. Frontiers in Physiology 2011, 2:90.
Heiss A., DuChesne A., Denecke B., Grotzinger J., Yamamoto K., Renne T., Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. Journal of Biological Chemistry 2003, 278:13333-13341.
Henrotin Y., Gharbi M., Mazzucchelli G., Dubuc J.E., De Pauw E., Deberg M. Fibulin-3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis and Rheumatism 2012, 64:2260-2267.
Henrotin Y., Martel-Pelletier J., Msika P., Guillou G.B., Deberg M. Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO(2), in the anterior cruciate ligament OA canine model. Osteoarthritis and Cartilage 2012, 20:787-790.
Huang L., Yoneda M., Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. Journal of Biological Chemistry 1993, 268:26725-26730.
Huang L., Harvie G., Feitelson J.S., Gramatikoff K., Herold D.A., Allen D.L., Amunngama R., Hagler R.A., Pisano M.R., Zhang, et al. Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis. Proteomics 2005, 5:3314-3328.
Jue D.M., Shim B.S., Kang Y.S. Inhibition of prostaglandin synthase activity of sheep seminal vesicular gland by human serum haptoglobin. Molecular and Cellular Biochemistry 1983, 51:141-147.
Kendall P.A., Saeed S.A., Collier H.O. Identification of endogenous inhibitor of prostaglandin synthetase with haptoglobin and albumin [proceedings]. Biochemical Society Transactions 1979, 7:543-545.
Lee C., Bongcam-Rudloff E., Sollner C., Jahnen-Dechent W., Claesson-Welsh L. Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Frontiers in Bioscience 2009, 14:2911-2922.
Ling S.M., Patel D.D., Garnero P., Zhan M., Vaduganathan M., Muller D., Taub D., Bathon J.M., Hochberg M., Abernethy, et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis and Cartilage 2009, 17:43-48.
Little C.B., Smith M.M. Animals models of osteoarthritis. Current Rheumatology Reviews 2008, 4:175-182.
Moreau M., Rialland P., Pelletier J.P., Martel-Pelletier J., Lajeunesse D., Boileau C., Caron J., Frank D., Lussier B., del Castillo J.R., et al. Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model. Arthritis Research and Therapy 2011, 13:R98.
Olivier E., Soury E., Risler J.L., Smih F., Schneider K., Lochner K., Jouzeau J.Y., Fey G.H., Salier J.P. A novel set of hepatic mRNAs preferentially expressed during an acute inflammation in rat represents mostly intracellular proteins. Genomics 1999, 57:352-364.
Olivier E., Soury E., Ruminy P., Husson A., Parmentier F., Daveau M., Salier J.P. Fetuin-B, a second member of the fetuin family in mammals. Biochemistry Journal 2000, 350:589-597.
Ombrellino M., Wang H., Yang H., Zhang M., Vishnubhakat J., Frazier A., Scher L.A., Friedman S.G., Tracey K.J. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 2001, 15:181-185.
Pelletier J.-P., Boileau C., Altman R.D., Martel-Pelletier J. Experimental models of osteoarthritis: Usefulness in the development of disease-modifying osteoarthritis drugs/agents. Therapy 2010, 7:621-634.
Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
Romisch J., Feussner A., Stohr H.A. Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects. Blood Coagulation and Fibrinolysis 2001, 12:375-383.
Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., Muller-Esterl W., Schinke T., Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. Journal of Clinical Investigation 2003, 112:357-366.
Schinke T., Amendt C., Trindl A., Poschke O., Muller-Esterl W., Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. Journal of Biological Chemistry 1996, 271:20789-20796.
Sumiya J., Asakawa S., Tobe T., Hashimoto K., Saguchi K., Choi-Miura N.H., Shimizu Y., Minoshima S., Shimizu N., Tomita M. Isolation and characterization of the plasma hyaluronan-binding protein (PHBP) gene (HABP2). Journal of Biochemistry 1997, 122:983-990.
Szweras M., Liu D., Partridge E.A., Pawling J., Sukhu B., Clokie C., Jahnen-Dechent W., Tenenbaum H.C., Swallow C.J., Grynpas M.D., Dennis J.W. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. Journal of Biological Chemistry 2002, 277:19991-19997.
Thompson S., Turner G.A. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. British Journal of Cancer 1987, 56:605-610.
Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., Crish J.F., Bebek G., Ritter S.Y., Lindstrom T.M., et al. Identification of a central role for complement in osteoarthritis. Nature Medicine 2011, 17:1674-1679.